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Redox equilibrium (a balance between 
oxidative and reductive processes) 
governs many essential biological 
processes such as cellular signaling 
pathways, transcription factor activ-
ity, chromatin remodeling, protein 
modification, membrane integrity, and 
mitochondrial function. Most notably, 
an imbalance in the redox equilibrium 
toward an increase in reactive oxygen 
species (oxidative stress) is involved 
in the pathophysiology of multiple 
diseases including atherosclero-
sis, neurodegeneration, cancer, and 
heart failure (Figure 1A). Specifically, 
animal studies have demonstrated 
that heart failure can be induced by 
activation of enzymes that generate 
reactive oxygen species (ROS), such 
as NADPH oxidases and xanthine 
oxidase, as well as by the inhibition of 
enzymatic pathways counterbalanc-
ing its production (such as catalase 
and glutathione peroxidase, superox-
ide dismutase, and the thioredoxin/
thioredoxin reductase system) (Gior-
dano, 2005).
In surprising new work, Rajasek-
aran et al. now demonstrate that 
“reductive stress”—defined as an 
abnormal increase of reducing equiv-
alents (in this case reduced glutathi-
one [GSH] and NADPH)—contributes 
to the molecular pathogenesis of a 
specific type of cardiomyopathy trig-
gered by protein aggregation (Figure 
1B; Rajasekaran et al., 2007). In a 
transgenic mouse model that mim-
ics a human cardiomyopathy caused 
by a mutation in the gene encoding 
αB-crystallin (R120GCryAB), protein 
accumulation was associated with 
an increase in heat shock proteins 
and enhanced generation of the 
reducing equivalents NADPH and 
GSH. This occurred in parallel with 
increased activity of antioxidative 
enzymes such as catalase and glu-
tathione peroxidase (Rajasekaran et 
al., 2007). As expected, antioxidative 
cytoprotective pathways mitigated 
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Oxidative stress due to the generation of reactive oxygen species has been implicated 
in many diseases. Rajasekaran et al. (2007) now make the surprising discovery that its 
counterpart “reductive stress,” caused by an increase in reduced glutathione, contributes 
to cardiomyopathy triggered by protein aggregation.
Figure 1. Redox Equilibrium and Cardiac Disease
(A) Oxidative stress contributes to heart failure and ischemic injury. Sources of reactive oxygen species (ROS) include mitochondria and enzymes 
such as the NADPH and xanthine oxidases. 
(B) Rajasekaran et al. (2007) show that reductive stress, due to an increase in the production of reduced glutathione (GSH) and NADPH, contributes 
to the pathophysiology of a mouse model of human cardiomyopathy. These mice express the human mutant αB-crystallin protein (R120GCryAB), 
which leads to protein aggregation and cardiomyopathy. In this model, enhanced activity of glucose-6-phosphate dehydrogenase (G6PD) increases 
production of NADPH, the cofactor used in the conversion of glutathione disulfide (GSSG) to GSH. The mutant αB-crystallin protein also induces 
expression of heat shock proteins, in particular Hsp25, and of catalase and glutathione peroxidase, which decrease ROS levels.
(C) Nitrosative stress, implicated in neurodegeneration, may also play a role in cardiac disease by promoting the accumulation of misfolded proteins. 
The transfer of a nitric oxide group to a critical cysteine thiol inactivates the molecular chaperone protein-disulfide isomerase. Nitrosative stress also 
targets a ubiquitin E3 ligase thereby impairing degradation of misfolded proteins by the proteasome.
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increased stress in response to 
overexpression of the mutant crys-
tallin protein. However, blocking the 
enzymatic activity of the rate-limiting 
enzyme in NADPH synthesis, glu-
cose-6-phosphate dehydrogenase 
(G6PDH), to 20% of normal partially 
rescued the cardiomyopathy in crys-
tallin mutant mice (although no long-
term data are provided as to whether 
cardiac remodeling and survival are 
also fully restored). Thus, increased 
G6PDH activity enhanced the pro-
duction of NADPH, a primary source 
of reducing equivalents, which 
appears to be necessary and suf-
ficient for cardiomyopathy in this 
experimental animal model.
Although it is unclear why limiting 
NADPH accumulation rescued only 
some features of cardiomyopathy 
(such as increased expression of 
brain natriuretic peptide), the study 
clearly indicates that reductive 
stress may causally contribute to 
cardiomyopathy induced by protein 
aggregation. The balance between 
molecular pairs, such as the ratio of 
NADPH to NADP or that of glutathi-
one to its oxidized form glutathione 
disulfide, regulates a number of tran-
scription factors controlling genes 
that detoxify reactive molecules 
and/or maintain cellular homeo-
stasis (Liu et al., 2005). Moreover, 
NADPH is a cofactor for multiple 
enzymes including the NADPH oxi-
dases and nitric oxide synthases. 
This raises the question of whether 
there is crosstalk between the path-
ways for reductive stress generated 
by G6PDH and the pathways for oxi-
dative or nitrosative stress.
In neurodegenerative diseases, 
nitrosative stress has been impli-
cated in misfolding and aggregation 
of proteins by affecting molecular 
chaperones and the ubiquitin pro-
teasome system (Figure 1C; Hess 
et al., 2005; Nakamura and Lipton, 
2007). The transfer of a nitric oxide 
group to a critical cysteine thiol 
inactivates the molecular chaper-
one protein-disulfide isomerase 
leading to polyubiquitination and 
activation of the unfolded protein 
response (Uehara et al., 2006). 
Nitrosative stress additionally tar-
gets an ubiquitin E3 ligase resulting 
in dysfunction of proteasomal deg-
radation. The inactivation of these 
and others targets (for example, 
heat shock protein 90) contributes 
to abnormal protein accumulation 
and neuronal damage (Nakamura 
and Lipton, 2007). Although the link 
between nitrosative stress and pro-
tein misfolding in heart failure has 
not yet been elucidated, it is likely 
that similar molecular mechanisms 
occur in the heart. An increase in 
G6PDH activity and the enhanced 
production of reducing equivalents 
might lead to an increase in nitrosa-
tive stress.
Interestingly, lowering G6PDH 
activity reduces the effects of loss 
of apolipoprotein E in mice, which 
has been used as a model of ath-
erosclerosis. These mice exhibit less 
release of superoxide anion from 
vascular cells and have a decreased 
nitrotyrosine content, indicating that 
reduced G6PDH activity modulates 
the nitroso-redox balance (Matsui et 
al., 2006). Although Rajasekaran et al. 
did not detect enhanced lipid peroxi-
dation (a measure of increased ROS 
production) in their transgenic mice, 
the potential role of nitrosative stress 
has not yet been addressed. The inhi-
bition of nitrosative stress by lower-
ing G6PDH activity may contribute to 
the amelioration of cardiomyopathy 
in the αB-crystallin mutant mice. In 
addition, it would be interesting to 
determine whether the increased 
reducing environment translates into 
altered redox equilibrium within the 
endoplasmatic reticulum (ER). The 
ER participates in protein processing 
and folding and possesses a rela-
tively oxidizing environment. Redox 
homeostasis is a prerequisite for ER 
activity (Gorlach et al., 2006), and 
disturbing this balance might impair 
the physiological function of the ER, 
thereby further amplifying the accu-
mulation of immature or denatured 
proteins.
Aberrant accumulation of proteins 
has been observed as a consequence 
of mutation or following the induction 
of oxidative stress. The demonstra-
tion that an increased reductive envi-
ronment is causally involved in the 
cardiomyopathy induced by expres-
sion of a mutant protein provides a 
link between the pathophysiologies 
of protein aggregation diseases and 
oxidative/reductive stress. This leads 
to the question of whether dysregula-
tion of oxidative/reductive/nitrosative 
stress is a general feature of diseases 
induced by protein misfolding. Clini-
cally, the findings by Rajasekaran et 
al. may not only uncover new thera-
peutic targets to modulate cardio-
myopathy induced by mutations in 
αB-crystallin but may also reconcile 
conflicting data from clinical trials 
assessing antioxidant therapies in 
patients with heart failure. Although 
some of the beneficial effects of 
drugs blocking the angiotensin II 
and the beta-adrenergic systems 
have been attributed, at least in part, 
to their ability to reduce ROS (Gior-
dano, 2005), the direct inhibition of 
ROS-producing enzymes (for exam-
ple, xanthine oxidase) has produced 
rather disappointing results. Thus, 
the “reductionist” view elegantly pre-
sented in the Rajasekaran et al. study 
gives rise to a more comprehensive 
appreciation for approaches that 
might be used to counter the mal-
adaptive mechanisms contributing to 
heart failure and other diseases.
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